# Organogenesis Holdings Inc.: filings

ORGO · Nasdaq · CIK 1661181 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/orgo.md) · [Financials](/companies/orgo/financials.md) · [Filings](/companies/orgo/filings.md) · [Insiders](/companies/orgo/insiders.md)

## Reports and events: 193 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 271, 8-K 108, 3 38, 10-Q 30, SC 13G/A 19, 425 16, CORRESP 14, SC 13G 14, SC 13D/A 13, S-4/A 12, 10-K 10, 4/A 10, DEF 14A 10, UPLOAD 10, 144 7, EFFECT 7, 10-K/A 6, 424B3 4, ARS 4, DEFA14A 4, PRE 14A 4, S-3 4, SCHEDULE 13D/A 4, 424B5 3, S-1/A 3, S-3/A 3, S-8 3, SC 13D 3, SCHEDULE 13G/A 3, SC TO-I/A 3, 10-Q/A 2, 25-NSE 2, 424B4 2, 5 2, 8-K/A 2, CT ORDER 2, DRS/A 2, DRSLTR 2, S-1 2, S-4 2, 8-A12B 1, 8-K12G3 1, CERTNAS 1, D 1, DRS 1, POS AM 1, RW 1, SCHEDULE 13G 1, SC TO-C 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:45 ET | [8-K](/filings/0001193125-26-338321.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-338321 |
| 2026-08-06 | 16:15 ET | [10-Q](/filings/0001193125-26-338049.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338049 |
| 2026-08-06 | 16:11 ET | [8-K](/filings/0001193125-26-338022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338022 |
| 2026-06-16 | 16:32 ET | [8-K](/filings/0001193125-26-272710.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-272710 |
| 2026-05-07 | 16:16 ET | [10-Q](/filings/0001661181-26-000008.md) | Quarterly report, period 2026-03-31 | 0001661181-26-000008 |
| 2026-05-07 | 16:11 ET | [8-K](/filings/0001661181-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001661181-26-000007 |
| 2026-04-30 | 16:17 ET | [DEF 14A](/filings/0001193125-26-197357.md) | Proxy statement, period 2026-06-15 | 0001193125-26-197357 |
| 2026-02-26 | 16:15 ET | [10-K](/filings/0001193125-26-076730.md) | Annual report, period 2025-12-31 | 0001193125-26-076730 |
| 2026-02-26 | 16:09 ET | [8-K](/filings/0001193125-26-076595.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076595 |
| 2026-02-23 | 17:02 ET | [8-K](/filings/0001193125-26-064270.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-064270 |
| 2025-12-29 | 16:31 ET | [8-K](/filings/0001193125-25-335425.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-335425 |
| 2025-11-06 | 16:28 ET | [10-Q](/filings/0001193125-25-269697.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269697 |
| 2025-11-06 | 16:23 ET | [8-K](/filings/0001193125-25-269654.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269654 |
| 2025-11-03 | 17:40 ET | [SCHEDULE 13D/A](/filings/0001193125-25-262869.md) | Ownership report, active investor, amended | 0001193125-25-262869 |
| 2025-09-25 | 17:00 ET | [8-K](/filings/0001193125-25-217810.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-217810 |
| 2025-08-07 | 16:16 ET | [10-Q](/filings/0000950170-25-105048.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105048 |
| 2025-08-07 | 16:11 ET | [8-K](/filings/0000950170-25-105032.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105032 |
| 2025-06-26 | 18:24 ET | [SCHEDULE 13D/A](/filings/0000950170-25-090530.md) | Ownership report, active investor, amended | 0000950170-25-090530 |
| 2025-06-24 | 16:33 ET | [8-K](/filings/0001193125-25-145767.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-25-145767 |
| 2025-05-12 | 16:23 ET | [DEF 14A](/filings/0001193125-25-117808.md) | Proxy statement, period 2025-06-23 | 0001193125-25-117808 |
| 2025-05-08 | 16:11 ET | [10-Q](/filings/0000950170-25-066962.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066962 |
| 2025-05-08 | 16:07 ET | [8-K](/filings/0000950170-25-066930.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066930 |
| 2025-04-29 | 17:14 ET | [10-K/A](/filings/0001193125-25-104050.md) | Annual report, amended, period 2024-12-31 | 0001193125-25-104050 |
| 2025-03-27 | 17:23 ET | [8-K](/filings/0001193125-25-065638.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-065638 |
| 2025-02-27 | 16:30 ET | [10-K](/filings/0000950170-25-029137.md) | Annual report, period 2024-12-31 | 0000950170-25-029137 |
| 2025-02-27 | 16:05 ET | [8-K](/filings/0000950170-25-029021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029021 |
| 2025-01-13 | 17:05 ET | [SCHEDULE 13D/A](/filings/0000950170-25-004892.md) | Ownership report, active investor, amended | 0000950170-25-004892 |
| 2025-01-03 | 17:18 ET | [SCHEDULE 13D/A](/filings/0000950170-25-001352.md) | Ownership report, active investor, amended | 0000950170-25-001352 |
| 2024-12-02 | 16:28 ET | [8-K](/filings/0000950170-24-132248.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-132248 |
| 2024-11-22 | 16:08 ET | [8-K](/filings/0000950170-24-130202.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-130202 |
| 2024-11-19 | 16:05 ET | [SC 13D](/filings/0001193125-24-261721.md) | Ownership report, active investor | 0001193125-24-261721 |
| 2024-11-14 | 20:09 ET | [SC 13D/A](/filings/0001193125-24-259026.md) | Ownership report, active investor, amended | 0001193125-24-259026 |
| 2024-11-13 | 09:28 ET | [8-K](/filings/0001193125-24-256699.md) | 1.01 Entry into a material agreement; 2.04 Item not in the standard list; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-256699 |
| 2024-11-12 | 16:15 ET | [10-Q](/filings/0000950170-24-125431.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125431 |
| 2024-11-12 | 16:05 ET | [8-K](/filings/0000950170-24-125331.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125331 |
| 2024-08-08 | 16:15 ET | [10-Q](/filings/0000950170-24-094009.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094009 |
| 2024-08-08 | 16:05 ET | [8-K](/filings/0000950170-24-093893.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093893 |
| 2024-06-21 | 16:12 ET | [8-K](/filings/0001193125-24-165670.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-165670 |
| 2024-05-09 | 16:25 ET | [10-Q](/filings/0000950170-24-057050.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057050 |
| 2024-05-09 | 16:05 ET | [8-K](/filings/0000950170-24-056885.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056885 |
| 2024-04-29 | 16:06 ET | [DEF 14A](/filings/0001193125-24-122223.md) | Proxy statement, period 2024-06-20 | 0001193125-24-122223 |
| 2024-04-03 | 17:26 ET | [8-K](/filings/0001193125-24-086129.md) | 8.01 Other events | 0001193125-24-086129 |
| 2024-02-29 | 16:31 ET | [10-K](/filings/0000950170-24-023150.md) | Annual report, period 2023-12-31 | 0000950170-24-023150 |
| 2024-02-29 | 16:05 ET | [8-K](/filings/0000950170-24-023059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023059 |
| 2023-11-09 | 16:11 ET | [10-Q](/filings/0000950170-23-062056.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062056 |
| 2023-11-09 | 16:10 ET | [8-K](/filings/0000950170-23-062041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062041 |
| 2023-08-09 | 16:34 ET | [10-Q](/filings/0000950170-23-040670.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040670 |
| 2023-08-09 | 16:23 ET | [8-K](/filings/0000950170-23-040643.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040643 |
| 2023-06-16 | 16:04 ET | [8-K](/filings/0001193125-23-168964.md) | 5.07 Shareholder vote results | 0001193125-23-168964 |
| 2023-05-10 | 16:47 ET | [10-Q](/filings/0000950170-23-020627.md) | Quarterly report, period 2023-03-31 | 0000950170-23-020627 |

Page 1 of 4. [Older](/companies/orgo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.